European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Human referrals
- Fenofibrato Pensa, Fenofibrato Ranbaxy
Community Register of medicinal products
List of referrals for human medicinal products
Fenofibrato Pensa, Fenofibrato Ranbaxy
| Product name: | Fenofibrato Pensa, Fenofibrato Ranbaxy |
| Also marketed in the EU under the name(s): | Fenofibrato Ranbaxy |
| INN: | fenofibrate |
| Indication: | Fenofibrato Pensa and Fenofibrato Ranbaxy contain fenofibrate, a drug of the fibrate class. It is used to reduce cholesterol levels in patients at risk of cardiovascular disease. It is used alone or in conjunction with statins in the treatment of hypercholesterolemia and hypertriglyceridemia. |
| Marketing Authorisation Holder: | Not available |
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 22/02/2013 | Referral | EMEA/H/A-31/1340 | (2013)1094 of 20/02/2013 |